The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MA...
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Abstract
Background:
Metabolic dysfunction associated steatotic liver disease (MASLD) is the most common cause of chronic hepatitis in adult and pediatric patients. Adolescents with severe MASLD can demonstrate a more aggressive disease phenotype as they more commonly develop liver fibrosis than BMI matched adults. Therefore, MASLD is the fas...
Alternative Titles
Full title
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9e6d545b89ee438d85619f2b12af33d6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e6d545b89ee438d85619f2b12af33d6
Other Identifiers
ISSN
1319-3767,1998-4049
E-ISSN
1998-4049
DOI
10.4103/sjg.sjg_428_23
